首页 › 基金 › Saratoga Research & Investment Management › JNJ

Saratoga Research & Investment Management 对 JNJ 的持仓历史

JOHNSON JOHNSON · 医疗保健

Saratoga Research & Investment Management 在 Q3 2026 的 13F 申报中披露持有 JNJ(JOHNSON JOHNSON)265,132 股,市值约 US$70.2M,约占其申报组合的 3.87%,在其申报持仓中市值排名第 10 位。 Saratoga Research & Investment Management 最近 13 个申报季度中有 13 个季度披露了 JNJ 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)265.13K 股
申报持仓市值$70.19M
组合权重3.87%
首次申报Q3 2023
最近变动减持
更新于2026-10-16

最后更新: 2026-10-16 · 来源: SEC EDGAR Form 13F-HR

Saratoga Research & Investment Management 对 JNJ 的持仓演变

Saratoga Research & Investment Management 于 Q3 2023 首次披露 JNJ 持仓:456,586 股(约 US$71.1M)。 该持仓在 Q4 2025 达到峰值 460,223 股,市值约 US$95.2M。 在 13 次申报中,Saratoga Research & Investment Management 2 次增持、10 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 265,132 股、市值约 US$70.2M,环比减持 -13,327 股。。 持仓曾出现大幅变动:Q2 2024 增持约 26% (随后一个季度股价上涨 11%)、Q1 2026 减持约 26% (随后一个季度股价上涨 4%)。

逐季持仓明细

季度股数金额变化
Q3 2023 456.59K $71.11M 新进
Q4 2023 435.14K $68.20M 减持
Q1 2024 439.52K $69.53M 增持
Q2 2024 551.75K $80.64M 增持
Q3 2024 532.44K $86.29M 减持
Q4 2024 520.35K $75.25M 减持
Q1 2025 504.42K $83.65M 减持
Q2 2025 501.42K $76.59M 减持
Q3 2025 485.62K $90.04M 减持
Q4 2025 460.22K $95.24M 减持
Q1 2026 339.44K $82.97M 减持
Q2 2026 278.46K $70.72M 减持
Q3 2026 265.13K $70.19M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 JNJ 与 13F 数据

JNJ(JOHNSON JOHNSON)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 JNJ,申报仓位最大的包括:贝莱德 (US$53.87B), 先锋集团 (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 JNJ 的基金

查看 JNJ 的全部基金持有人 →

常见问题

How long has Saratoga Research & Investment Management held JNJ?

Saratoga Research & Investment Management has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Saratoga Research & Investment Management's current position in JNJ?

As of Q3 2026, Saratoga Research & Investment Management holds 265.13K shares of JNJ (JOHNSON JOHNSON), valued at $70.19M, representing 3.87% of its reported portfolio and ranking #10.

Has Saratoga Research & Investment Management been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Saratoga Research & Investment Management reduced its position in JNJ. The position peaked in Q4 2025 at 460.22K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include 贝莱德, 先锋集团, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.